12 April,2023 05:10 PM IST | New Delhi | PTI
Representative image. Pic/Istock
Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot.
Reacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand.
Also Read: Covid-19 cases rising as the infection moves towards endemic stage in India
ALSO READ
India’s Ravindra Jadeja (left) and Jasprit Bumrah during their 35-run
Indian Army arrests Lashkar-e-Taiba group guide in Poonch dst of Jammu-Kashmir
Two terrorists killed as Army foils infiltration bid along LoC in J-K's Rajouri
Indian Army soldier critically injured in suspected terror attack on Jammu camp
India to observe state mourning on April 26 for Pope Francis's funeral
"Just as a precaution, at risk we have done it so that people have a Covishield as a choice if they want it," Poonawalla told PTI on restarting of manufacturing of the vaccine.
The company had stopped manufacturing of Covishield in December 2021.
On Covovax which has been approved as a booster dose for 18-years and above, he said, "We have six million doses ready but the demand is exactly zero."
Covovax booster is now on the CoWin app, he said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
